Recent advances in paediatric neuro-oncology

Area of Science:

• Pediatric oncology
• Neuro-oncology
• Cancer biology

Background:

• Pediatric central nervous system (CNS) malignancies are the most common childhood solid tumors, accounting for 20-25% of all pediatric malignancies.
• Tumor biology research is revealing potential targets for novel therapies.
• Recent studies are influencing future clinical trial designs.

Purpose of the Study:

• To review recent findings in pediatric central nervous system malignancies.
• To highlight advancements in understanding tumor biology and treatment strategies.
• To emphasize the importance of clinical trials for future progress.

Main Methods:

• Review of institutional and national studies published in the last 12-18 months.
• Analysis of treatment outcomes for various pediatric CNS tumor types.
• Identification of emerging prognostic markers and therapeutic approaches.

Main Results:

• Low-grade gliomas may benefit from reduced radiation toxicity with stereotactic radiotherapy.
• Adjuvant chemotherapy can improve survival in select high-grade gliomas.
• Ependymomas: completeness of resection and radiotherapy are key; chemotherapy may delay radiation in infants.
• Primitive neuroectodermal tumors: prognostic markers identified; localized medulloblastomas show promise with reduced radiotherapy and chemotherapy; supratentorial PNETs focus on local control.

Conclusions:

• Progress in rare pediatric CNS malignancies necessitates national/multinational prospective clinical trials.
• Integrating biological studies into trials is crucial for advancing treatment.
• Strong encouragement for participation in these collaborative clinical trials is essential.